AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in pat ...
AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation - AUDIOWOLF AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in pat ...